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Background: Animal neurotoxin peptides are valuable probes for investigating ion channel structure/function
relationships and represent lead compounds for novel therapeutics and insecticides. However, misfolding and
aggregation are common outcomes when toxins containing multiple disulﬁdes are expressed in bacteria.
Methods: The β-scorpion peptide toxin Bj-xtrIT from Hottentotta judaica and four chaperone enzymes (DsbA,
DsbC, SurA and FkpA) were co-secreted into the oxidizing environment of the Escherichia coli periplasm.
Expressed Bj-xtrIT was puriﬁed and analyzed by HPLC and FPLC chromatography. Its thermostability was
assessed using synchrotron radiation circular dichroism spectroscopy and its crystal structure was determined.
Results: Western blot analysis showed that robust expression was only achieved when cells co-expressed the
chaperones. The puriﬁed samples were homogenous and monodisperse and the protein was thermostable.
The crystal structure of the recombinant toxin conﬁrmed that it adopts the native disulﬁde connectivity and fold.
Conclusions: The chaperones enabled correct folding of the four-disulﬁde-bridged Bj-xtrIT toxin. Therewasno ap-
parent sub-population of misfolded Bj-xtrIT, which attests to the effectiveness of this expression method.
General signiﬁcance:We report the ﬁrst example of a disulﬁde-linked scorpion toxin natively folded during bac-
terial expression. Thismethod eliminates downstreamprocessing steps such as oxidative refolding or cleavage of
a fusion-carrier and therefore enables efﬁcient production of insecticidal Bj-xtrIT. Periplasmic chaperone activity
may produce native folding of other extensively disulﬁde-reticulated proteins including animal neurotoxins. This
work is therefore relevant to venomics and studies of a wide range of channels and receptors.© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY license.1. Introduction
A diverse array of animals including scorpions, spiders, conus snails
and sea anemones produce venom replete with small peptide neuro-
toxins to incapacitate prey or predators. Most of these toxins modify
the function of ion channels of the nervous, muscular or cardiovascular
systems [1]. The toxins display variability in length, sequence, folds and
molecular targets but share a common structural property in that in
each case a network of disulﬁde bridges stabilizes their respective fold
[2]. This extensive reticulation establishes the tertiary structure that
presents the bioactive surface as well as conferring signiﬁcant thermo-
stability [3] and resistance to proteolysis.
β-Scorpion toxins are polypeptides of 60–76 residues stabilized
by four disulﬁde bridges [4]. They bind with nanomolar afﬁnity to anallace).
niversidade de Sao Paulo, Sao
. Open access under CC BY license.extracellular receptor (site 4) of voltage-gated sodium channels
[5]. β-Toxins induce a hyperpolarizing shift of the voltage-dependence
of activation via a voltage-sensor trapping mechanism, whereby toxin-
mediated interactions stabilize a persistently-activated conformation
of the channel domain II voltage sensor [6,7]. The extensively-
characterized Bj-xtrIT from Hottentotta judaica (Fig. 1) is a member of
the ‘excitatory’ (inducing a spastic paralysis) anti-insect β-toxins
[8–11] and its structure was the ﬁrst of this class to be solved by X-ray
crystallography [11].
The low cost, simplicity, speed-of-growth and wide-spread avail-
ability of bacterial-culturing facilities have made Escherichia coli the
host organism of choice for recombinant protein production. However,
the reducing environment of the E. coli cytoplasm can hinder
disulﬁde-bond formation and render cysteine-containing proteins
prone to misfolding and aggregation [12]. Previous reports of Bj-xtrIT
prepared from E. coli have required the solubilization of misfolded
toxin from inclusion bodies under denaturing and reducing condi-
tions [8]. Other reports of recombinant scorpion toxins circumvent
this step by using a fusion chimera to rescue protein from incorporation
into inclusion bodies [13,14]. However, this latter approach still requires
an additional processing step to cleave the fusion partner and yield the
mature toxin. Further downstreamprocessing typically involves in vitro
Fig. 1. Sequence and disulﬁde-connectivity map of Bj-xtrIT-(His6).
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of glutathione to produce disulﬁde-bridge shufﬂing with the goal of
obtaining native connectivity. A post-folding puriﬁcation step is often
required to isolate the correct structural isomer from the misfolded en-
semble. Indeed, identifying which elution fraction from a chromatogra-
phy step corresponds to the correctly-folded isomer can require
arduous bio-assay, electrophysiological or structural studies.
In this study we show that the Bj-xtrIT β-scorpion toxin can be
expressed in its natively-folded conformation by secretion of the poly-
peptide into the oxidizing environment of the E. coli periplasm [15].
However, we found that the toxin could not be over-expressed and pu-
riﬁedwhen secreted alone. Instead, periplasmic co-secretion of the four
bacterial chaperone proteinsDsbC, DsbA, SurA and FkpA encoded by the
pTUM4 plasmid [16] enabled robust toxin over-expression. Chromato-
graphic analyses demonstrated the homogeneity and monodispersity
of the puriﬁed sample and synchrotron radiation circular dichroism
spectroscopy conﬁrmed that the recombinant toxin was thermostable.
Finally, we crystallized and solved the structure of recombinant Bj-
xtrIT to conﬁrm that it indeed adopts the correctly-reticulated native
fold.
2. Material and methods
2.1. Molecular biology
A gene encoding the Bj-xtrIT sequence (Swiss-Prot accession code
P56637) with a bacterial codon bias and a C-terminal hexa-histidine
tag was synthesized by Gene Oracle (California, USA). The gene was
PCR-ampliﬁed using the primers 5′-GGTTTCGCTACCGTAGCGCAGGCC
AAAAAAAACGGCTATCCGCTGGATCGTAATGGTA-3′ and 5′-CAAGCTTA
TTAGTGATGGTGATGGTGATGCGATCCGCTCGGAATAATCTGCACGT-3′ and
sub-cloned into the pASK-IBA32 expression vector (IBA GmbH,
Göttingen, Germany) using the overlap extension PCR cloning method
[17] with Phusion polymerase (New England Biolabs). DH5α
chemically-competent E. coli cell (New England Biolabs) transformants
were plated overnight at 37 °C on 100 μg/ml ampicillin (AMP) agar
plates. Plasmid-DNA isolated from single colonies was sequenced to
verify that the construct had the correct sequence (Supplementary
Fig. 1).
2.2. Expression and periplasm extraction
Chemically-competent BL21 (DE3) E. coli cells (Invitrogen) were
transformed with the pTUM4 plasmid (generously provided by A.
Skerra of Technische Universität München, Freising-Weihenstephan,
Germany) and plated on agar containing 25 μg/ml chloramphenicol
(CAM) overnight at 37 °C. A single colony was used for the growth
and preparation of 200 μl aliquots of cells, whichweremade chemically
competent using themagnesium/calcium chloridemethod as described
[18]. These pTUM4 transformantswere further transformedwith pASK-
IBA32 plasmid encoding the Bj-xtrIT-(His6) gene and plated on agar
with 100 μg/ml AMP plus 25 μg/ml CAM overnight at 37 °C. Alterna-
tively, chemically-competent BL21 E. coli cells not harboring the
pTUM4 plasmid were transformed with the pASK-IBA32/Bj-xtrIT-
(His6) and plated on AMP plates.
A single colony was used to inoculate LB medium (Melford) contain-
ing 100 μg/mlAMPand, for cells harboring pTUM4, additionally 25 μg/mlCAM. 1 l of antibiotic-supplemented LB medium was inoculated with
10 ml of pre-culture (grown overnight at 37 °C) and shaken at
200 rpm at 37 °C until an OD600 = 0.5 was reached. Toxin expression
was induced using 200 μg/l anhydrotetracycline (Fluka) and the culture
was grown at 26 °C for 8 h. Cells were harvested at 4400 g for 15 min
at 4 °C. The supernatant was discarded and the pellet was placed on ice
and resuspended in 10 ml of ice-cold periplasm-extraction buffer:
500 mM sucrose, 1 mM EDTA, 100 mM Tris–HCl; pH 8. Following
30 min incubation on ice, spheroplasts were spun down at 5000 g for
15 min at 4 °C and the supernatant was further centrifuged at 27000 g
to yield the clariﬁed periplasm fraction.
2.3. Toxin puriﬁcation
Bj-xtrIT-(His6) toxin was puriﬁed by immobilized-metal afﬁnity
chromatography (IMAC) using a 5 ml HisTrap HP nickel column (GE
Healthcare). The column was pre-equilibrated with 20 mM Tris;
pH 7.8, 150 ml NaCl, 20 mM imidazole. Periplasm extract was ﬁltered
(0.2 μm ﬁlter) and passed through the column overnight at 4 °C using
a peristaltic pump. An Äkta puriﬁer (GE Healthcare) was used to apply
a linear gradient of imidazole (20 mM to 500 mM) to wash and elute
the toxin. The elution was concentrated using a Vivaspin (Sartorius)
with a 5 kDa molecular weight cut-off. Size exclusion chromatography
using a Superdex 75 10∕300 (GE Healthcare) column pre-equilibrated
with 20 mM Tris; pH 7.8, 150 ml NaCl and operated with a ﬂow-rate
of 0.5 ml/min provided the ﬁnal preparative step. A 20 μl aliquot of the
IMAC elution was also applied to a Jupiter C18 5 μm 250 mm × 4.6 mm
reverse-phase HPLC analytical column (Phenomenex) and eluted using
a 5% to 95% acetonitrile gradient.
2.4. SDS-PAGE and Western blot analysis
Sampleswere prepared for SDS-PAGE by heating at 90 °C for 10 min
with 2.5% (w/v) SDS, 2% (v/v) β-mercaptoethanol. 10 μl aliquots were
electrophoresed for 25 min at 200 mV using a 4–12% NuPAGE Bis-Tris
gel (Invitrogen); molecular weight markers were Ultra-Low Range
(Sigma). The gel was either stained with SimplyBlue SafeStain
(Invitrogen) or used with an iBlot system (Invitrogen) to transfer pro-
tein to a nitrocellulose membrane for Western blotting. The blot was
probed with an anti-His (C-term) antibody conjugated with alkaline
phosphatase (Invitrogen) and developed using a Sigmafast 5-bromo-
4-chloro-3-indolyl phosphate/nitro blue tetrazolium tablet (Sigma).
2.5. Synchrotron radiation circular dichroism (SRCD) spectroscopy
Bj-xtrIT-(His6) toxin puriﬁed by IMAC and size-exclusion chroma-
tography was prepared for thermal denaturation studies by buffer-
exchanging the sample into 20 mM sodiumphosphate; pH 7.8, 5% glyc-
erol using a 5 ml HiTrap Desalting column (GE Healthcare). The SRCD
spectrum of Bj-xtrIT-(His6) toxin (3.3 mg/ml) was collected using a
0.0015 cm pathlength demountable quartz cell (Hellma Scientiﬁc) at
beamline CD1 at the Institute for Storage Ring Facilities (Aarhus,
Denmark). Data were collected over the wavelength range of 270 to
175 nmwith a 1 nm interval and 2 s dwell time. Protein was incubated
at temperatures ranging from 25 to 85 °C, in 5 °C steps allowing 5 min
equilibration at each temperature. At each temperature point three
scans of either the sample or baseline (buffer without protein) were
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equilibrium had been reached prior to spectral data collection. The
three scans were averaged and the averaged baseline spectrum was
subtracted from the averaged sample spectrum, smoothed with a
Savitzky–Golay ﬁlter, calibrated versus a camphorsulfonic acid stan-
dard, and scaled to Delta Epsilon units using a mean residue weight of
113. All data processingwas done using CDTools software [19]. Second-
ary structure analyses used the Dichroweb server [20], with database
SP175 [21] and the ContinLL [22] algorithm.
2.6. X-ray crystallography
Puriﬁed Bj-xtrIT-(His6) toxin at a concentration of 10 mg/ml was
mixed 1:1 (v/v) with 0.2 M NaCl, 0.1 M Bis-Tris; pH 5.5, 29% PEG
3350. 2 μl hanging drops were equilibrated at 16 °C against 500 μl of
the crystallization solution. Crystals appeared within one week and
were prepared for cryo-freezing by immersing in crystallization solu-
tion supplemented with 35% PEG 3350.
Datawere collected on the Proxima1 beamline at the Soleil Synchro-
tron, France to amaximum resolution of 1.7 Å. Integration and scaling of
the data were carried out using XDS [23] with the SCALA program from
CCP4 [24] being used for further data analysis. Molecular replacement
was carried out using the native toxin structure (PDB ID: 1BCG) with
the PHASER package [25], as implemented in CCP4. Reﬁnement was
carried out using the BUSTER suite [26]. Structure analysis and building
were carried out using COOT [27]. A ﬁgure was produced using PyMOL
(DeLano Scientiﬁc, CA, U.S.A.). Coordinates of Bj-xtrIT-(His6) have been
deposited in the Protein Data Bank (PDB ID: 4KYP).
3. Results
3.1. Periplasmic co-secretion of chaperones enables Bj-xtrIT-(His6)
over-expression
To produce natively-folded scorpion toxin directly from a bacterial
expression system, we sub-cloned the Bj-xtrIT-(His6) gene into the
pASK-IBA expression vector, thereby introducing an OmpA secretion
signal at the toxin N-terminus. This sequence directs polypeptide secre-
tion via the Sec pathway in the oxidative compartment of the E. coli
periplasm. The signal is subsequently cleaved by an endopeptidase, pro-
ducing the target gene product without an N-terminal adduct. The level
of Bj-xtrIT-(His6) expression was extremely low (Fig. 2A; lane 1). We
attempted to use immobilized-metal afﬁnity chromatography to isolateFig. 2. Expression and puriﬁcation of Bj-xtrIT-(His6). (A) Western blot analysis: lane M,
molecular weight markers; lane 1, periplasmic cell extract of E. coli BL21/pASK-IBA32;
and lane 2, periplasmic cell extract of E. coli BL21/pASK-IBA32/pTUM4. (B) SDS-PAGE anal-
ysis following IMAC puriﬁcation: lane M, molecular weight markers; lane 1, periplasmic
cell extract of E. coli BL21/pASK-IBA32; and lane 2, periplasmic cell extract of E. coli
BL21/pASK-IBA32/pTUM4.soluble toxin from theperiplasmic extract in order to obtain amore con-
centrated solution of protein for visualization using SDS-PAGE. The
toxin in its reduced form should migrate with a molecular mass of
~9.4 kDa but no band was observed on a 4–12% SDS-PAGE gel
(Fig. 2B; lane 1). These results are representative of Bj-xtrIT-(His6) ex-
pression trials using three individual E. coli transformants and suggest
that the secreted protein may be inherently labile.
Then cells were co-transfected with the pTUM4 plasmid [16] to de-
termine the effect of chaperone activity on Bj-xtrIT-(His6) expression.
This helper vector encodes genes for the DsbA and DsbC members of
the thioredoxin superfamily [28] and genes for SurA and FkpA
peptidyl-prolyl cis/trans-isomerases. These enzymes are all expressed
under a constitutive promoter and secreted into the periplasm, where
they are available to operate on newly-secreted toxin. Under identical
conditions of cell growth and genetic induction, there was signiﬁcant
Bj-xtrIT-(His6) expression (Fig. 2A; lane 2) from cells harboring
pTUM4. In addition, protein could be puriﬁed to homogeneity (Fig. 2B;
lane 2) with a ﬁnal yield of ~0.3 mg/l culture. Hence, the presence of
chaperones in the periplasm promoted toxin expression and yielded
suitable amounts of soluble protein for subsequent biochemical and
structural characterization.
3.2. Bj-xtrIT-(His6) homogeneity
Bj-xtrIT-(His6) from pTUM4-plasmid transformants was puriﬁed by
IMAC (Fig. 2B) and analyzed by size exclusion chromatography. The elu-
tion proﬁle shows a single symmetrical peak that was retained longer
than the void volume (Fig. 3A). The IMAC eluate was also examined
using analytical RP-HPLC and the elution proﬁle also exhibited a singleFig. 3. Chromatography analysis of Bj-xtrIT-(His6) IMAC eluate. (A) Size-exclusion HPLC.
(B) Analytical reverse-phase FPLC.
Table 1
Crystallography statistics for PDB ID: 4KYP.
Data processing statistics
Space group C2221
a, b, c (Å) 41.87, 88.56, 183.58
α, β, γ (°) 90.0, 90.0, 90.0
Resolution (Å) 44–1.7 (1.77–1.7)
Number of reﬂections used in reﬁnement 26,392
Completeness (%) 44–2.1 (97.9)
2.1–1.7 (29.6)
I/σ(I) 9.12 (1.4)
R-sym (%) 10.2 (69.5)
CC 1/2 97.9 (40.1)
Reﬁnement statistics
R cryst 19.93 (21.3)
R free 23.06 (28.0)
Wilson B-factor (Å2) 24.04
Bond lengths (Å) 0.010
Bond angles (°) 0.99
Highest resolution shell is shown in parentheses.
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protein was soluble, homogenous and mono-disperse.
3.3. Bj-xtrIT-(His6) thermostability
The SRCD spectrum of the toxin at 25 °C displays a large negative
peak at 207 nm (Fig. 4), which matches the previously-reported CD
spectrum of Bj-xtrIT [9], plus an additional positive peak at 190 nm
with a shoulder at 185 nm (not seen previously as that study had
used conventional CD spectroscopy). The estimate of the secondary
structural content from the SRCD data was 25% α-helix, 23% β-sheet
and 52% other structures, very similar to the content determined from
the crystal structure of Bj-xtrIT (PDB ID: 1BCG), calculated using the
2Struc server (26% α-helix, 20% β-sheet and 54% other) [29].
The thermostability of Bj-xtrIT-(His6) was then investigated using
SRCD spectroscopy, which represents the ﬁrst application of this sensi-
tive technique to this class of protein. Using SRCD spectroscopy as op-
posed to CD spectroscopy enabled a more accurate observation of the
peak at ~186 nm, which is indicative of a denatured protein. The entire
SRCD spectrumwasmonitored from25 to 85 °C as the temperaturewas
increased in 5 °C steps. Discrete but relatively small differences from the
original spectrum were observed with increasing temperature, with a
reduction of the intensity of the peak at 207 nm being the most appar-
ent change. Nevertheless, even at very high temperatures the SRCD
spectra did not resemble one typical for a denatured protein. The esti-
mate of the secondary structural content at 85 °C was 13% α-helix,
29% β-sheet and 58% other structures, which is still similar to the
starting structure. Localized denaturation of the α-helical regions
could account for the temperature-dependent changes observed by
SRCD signal, but overall the protein displayed signiﬁcant thermostabil-
ity that is consistent with a correctly-reticulated toxin structure.
3.4. Recombinant Bj-xtrIT adopts the native fold
Crystals of Bj-xtrIT-(His6) diffracted to 1.7 Å resolution (Table 1) and
were solved by molecular replacement using the previously-reported
Bj-xtrIT structure [11]. Recombinant Bj-xtrIT-(His6) has both the
βαββα-fold and C1–C4, C2–C6, C3–C7, and C5–C8 disulﬁde connectivi-
ty of the native fold (Figs. 1 and 5A). An all-atom structural superimpo-
sition of Bj-xtrIT-(His6) with the untagged Bj-xtrIT structure [11]
(Fig. 5B) shows that there is a root-mean-square deviation (RMSD) of
0.45 Å. The structures differ only in side-chain rotamers for someFig. 4. Thermal denaturation of Bj-xtrIT-(His6) monitored by SRCD spectroscopy. Toxin
was incubated over the temperature range from 25 °C (bold line) to 85 °C (dash line) in
5 °C increments (intermediate curves are in gray).residues located on the surface of the toxin, reﬂecting the difference in
crystal contacts that the toxin formsunder different crystal packing con-
ditions (space groups C2221 vs I4122). Nevertheless the backbone
atoms and disulﬁde groups all superimpose and show that recombinant
Bj-xtrIT-(His6) was expressed with the native conformation.
4. Discussion
Bacterial recombinant expression of toxins with multiple disulﬁde
bonds can be a challenging task that requires considerable optimization
of conditions. In particular, post-puriﬁcation in vitro oxidative refolding
is often necessary to yield functionally-folded toxin, which may need
to be subsequently identiﬁed and separated from non-physiological
structural isomers. Herewe report an expression strategy that produced
natively-folded β-scorpion toxin in the E. coli bacterium. Over-
expression and puriﬁcation of Bj-xtrIT-(His6) were achieved when a
suite of chaperones was co-secreted into the periplasm. With biochem-
ical, biophysical and structural characterization, we demonstrated that
the toxin adopts a single conformation with the native fold.
Periplasmic secretion using E. coli has proved a successful expression
strategy for the functional folding of many disulﬁde-rich proteins e.g.
antibody fragments [30]. However, to date there have been no reports
of the successful application of this strategy for scorpion toxins lacking
a fusion carrier [31]. Indeed, we found that toxin over-expression
could not be achieved solely by secreting Bj-xtrIT into the periplasm.
β-Toxins contain eight cysteines and different disulﬁde pairings can
theoretically produce 105 structural isomers [32]. Therefore, although
the oxidative environment of the periplasm enables disulﬁde formation,
the potential formisfolding through cysteinemispairing is considerable.
An additional factor that can compromise folding is cis–trans isomeriza-
tion of proline residues: Bj-xtrIT has ﬁve prolines and each adopts the
trans conﬁguration in the native fold. In the absence of a mechanism
for correcting protein misfolding, the toxin may be susceptible to pro-
teolytic degradation and aggregation in the periplasm [33], which
could account for the poor expression and our inability to yield the pu-
riﬁed product without pTUM4 co-transfection.
The pTUM4 plasmid secretes four bacterial folding-catalysts into the
periplasm [16]. DsbA and DsbC are thiol-disulﬁde oxidoreductases that
work in tandem to produce disulﬁde-bridge shufﬂing in a polypeptide
substrate and permit the stable low-energy conformation of the native
fold to be adopted. Speciﬁcally, DsbA functions by rapidly transferring
a disulﬁde bond to a substrate to catalyze disulﬁde bridge formation.
DsbC has two thioredoxin domains and performs an isomerization
role by breaking unstable disulﬁdes. A covalent complex is formed
with the substrate, which allows a second reactive cysteine in the
misfolded protein to react and ideally form a more stable disulﬁde
Fig. 5. Crystal structures. (A) 1.7 Å crystal structure of Bj-xtrIT-(His6) (PDB ID: 4KYP) colored by secondary structure (α-helices; red, β-strands; blue; disulﬁde bridges, yellow). (B) Superpo-
sition of Bj-xtrIT-(His6) (PDB ID: 4KYP) (pink backbone; disulﬁde bridges as red dots) and native Bj-xtrIT (PDB ID: 1BCG) (gray backbone; disulﬁde bridges as black dots).
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folding-catalyst is peptidyl-prolyl cis/trans-isomerases. The main sub-
strate for SurA and FkpA enzymes is prolyl-iminopeptide bonds, al-
though they appear additionally to have a general chaperone activity
that promotes protein folding. Successful chaperone-mediated folding
of the target protein has the added advantage that cell lysis is
suppressed, which has been attributed to the toxic effects of protein ag-
gregation in the periplasm that can occur in the chaperones' absence
[16].
There are many advantages of using this chaperone-mediated ex-
pression strategy to produce recombinant β-toxins, including the elim-
ination of downstream processing steps of solubilization and refolding
from inclusion bodies [8] or cleavage of a fusion carrier [13,14]. With
the current method, no such procedures need be undertaken, as the
already-folded toxin can be isolated directly from the periplasm; the
procedure is further simpliﬁed as there is no need for post-folding sep-
aration of structural isomers. Periplasmic extraction also functions as a
pseudo-puriﬁcation step as intact cell bodies are separated as sphero-
plasts, preventing the release of cytoplasmic contaminants including
deleterious proteases. Finally, as the immature polypeptide encodes
an N-terminal OmpA secretion signal that is subsequently cleaved in
the periplasm, the ﬁrst residue of the mature toxin does not need to
bemethionine to function as the start codon for transcription initiation,
which is the case with directly-expressed polypeptides. In addition, be-
cause there appears to be little or no dependence of the cleavage efﬁ-
ciency of the OmpA secretion signal based on the nature of the amino
terminal residue of themature peptide [34] this method should be gen-
erally applicable to polypeptides containing any type of N-terminal
residue.
The toxin composition of venom from arthropods, mollusks and cni-
darians is characteristically diverse. A multitude of sequence variants
within each toxin class contributes to this heterogeneity and the number
of small, multidisulﬁde-bridged animal neurotoxins may total several
million [35]. These peptides represent valuable probes for investigating
structure–function relationships in ion channels andmay also be exploit-
able as novel therapeutics, e.g. a calcium-channel blocking ω-conotoxin
[36] has been commercialized as the analgesic ziconotide (Prialt™).
Toxins that display speciﬁcity for a single molecular target e.g. the pain-
associated sodium-channel Nav1.7 isotype [37], are particularly desirable.
However, the isolation of these toxins in signiﬁcant quantities from natu-
ral sources is unrealisticwhen they are present at very lowconcentrations
in the venom. The cloning of toxin genes can offer a solution to this prob-
lem, so development of robust methods for functional expression of
toxins in bacteriawill support the efforts of venomics projects. The report
of a spider toxin functionally-expressed in the E. coliperiplasm (albeit as a
fusion protein with DsbC coupled to the N-terminus) [38] supports our
suggestion that chaperone-mediated periplasmic expressionmay be gen-
erally applicable for functional expression of members from differenttoxin classes. However, this work further extends the efﬁcient prepara-
tion of such toxins by eliminating cleavage and additional puriﬁcation
steps.
5. Conclusion
Wereport an expression strategy that uses chaperone-mediated fold-
ing in the periplasm to produce correctly-folded Bj-xtrIT β-scorpion
toxin in E. coli. This represents the ﬁrst reported instance of a disulﬁde-
linked toxin puriﬁed directly from a bacterial expression systemwithout
the use of a fusion partner, or requiring solubilization of the expressed
toxin from inclusion bodies, followed by refolding in vitro. Furthermore
it yields a single conformation with the native disulﬁde connectivity.
This expression strategy represents a time- and cost-effective solution
that will enable routine toxin production and mutagenesis to aid in the
investigation of channel structure–function relationships.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbagen.2013.08.021.
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